Clinical trial

"DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC…

NCT00238641 · Stanford University, Other · Completed

Key facts

NCT number NCT00238641
Title "DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"
Official title "DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"
Lead sponsor Stanford University, Other
Collaborators Elan Pharmaceuticals Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Cerebral Palsy
Intervention type Drug
Interventions Botulinum Toxin type B
Enrollment 10
Start date Jan 1, 2002
Completion May 1, 2005
First posted Oct 13, 2005
Last update posted Oct 13, 2005
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies